Literature DB >> 33377030

In Vitro Derivation of Quiescent Mouse Embryonic Stem Cells Based on Distinct Mitochondrial Activity.

Le Tran Phuc Khoa1, Yali Dou1.   

Abstract

Embryonic diapause is a naturally occurring strategy in mammals that determines successful rates of gestation under unfavorable conditions. This dormant state can be captured in the form of quiescent mouse embryonic stem cells (ESCs). Here, we present a step-by-step protocol to derive quiescent ESCs that naturally exist in culture by harnessing the heterogeneity of mitochondrial activity. The derived quiescent ESCs with low mitochondrial activity can be utilized as a surrogate to study stages of early embryonic development. For complete details on the use and execution of this protocol, please refer to Khoa et al. (2020).
© 2020 The Author(s).

Entities:  

Mesh:

Year:  2020        PMID: 33377030      PMCID: PMC7757300          DOI: 10.1016/j.xpro.2020.100136

Source DB:  PubMed          Journal:  STAR Protoc        ISSN: 2666-1667


Before You Begin

Timing: 1–2 days This protocol includes methodologies of ground-state embryonic stem cell (ESC) culture, cell labeling, fluorescence-activated cell sorting (FACS) and in vitro embryoid body (EB) differentiation. Before starting this protocol, all reagents and the ESC line should be purchased and prepared in a ready-to-use mode with careful considerations. Geltrex preparation Thaw the Geltrex 18 h at 4°C. Geltrex should be aliquoted (200 μL/tube), stored at −20°C and used within 3 months. Thaw an aliquot of Geltrex 18 h at 4°C. Gently mix the Geltrex with 19.8 mL of DMEM/F-12 in a 50 mL conical tube. Pre-chill 24-well or 6-well cell culture plates in −20°C for at least 15 min before use. Add 0.5 mL or 1 mL of the diluted Geltrex into the above 24-well or 6-well plates, respectively. Incubate the Geltrex-coated plates in the cell culture incubator for at least 1 h. Leave the Geltrex-coated plates in the laminar flow hood for at least 30 min but no more than 1 h. Gently aspirate the Geltrex, add Dulbecco’s Phosphate-Buffered Saline (DPBS) into the plates, and store in the cell culture incubator. The Geltrex-coated plates are ready to use and stable for 1 week. CRITICAL: Geltrex is very easy to gel at room temperature (RT, 25°C–27°C), researchers are highly recommended to follow the above steps to maintain the quality of Geltrex. We strongly suggest that all tips and plastic pipettes should be pre-chilled at −20°C for at least 15 min before touching the Geltrex. PD0325901 (10 mM stock): dissolve 5 mg of PD0325901 into 1.04 mL of Dimethyl Sulfoxide (DMSO). PD0325901 stock can be aliquoted at 50 μL/tube, stored at −20°C and used within 6 months. CHIR99021 (30 mM stock): dissolve 25 mg of CHIR99021 into 1.79 mL of DMSO. CHIR99021 stock can be aliquoted at 50 μL/tube, stored at −20°C and used within 6 months. 2i stock (PD0325901, 5 mM plus CHIR99021, 15 mM): mix an equal volume of PD0325901 and CHIR99021 from steps 2 and 3. 2i stock can be stored at −20°C and used within 6 months. Preparation of culture medium: ESCs are routinely cultured in N2B27/2i/LIF media. N2B27 medium consists of a 1:1 mixture of DMEM/F12 and Neurobasal, N2 (1:100 dilution), B27 (1:100 dilution), 2 mM Glutamine, Penicillin/Streptomycin (1:100 dilution) and 0.055 mM 2-mercaptoethanol. 2i (1:5,000 dilution) and LIF (1,000 U/mL) are added as the last components. Since DMEM/F12 already contains L-Glutamine, only another 200 μL is required. CRITICAL: To maintain the stability of all chemicals and get reproducible results, the culture medium should be prepared and used within one week. In addition, each component should be routinely tested for lot-to-lot variability by comparing cell morphology and growth rate between old and new media. EB media: KnockOut™ DMEM, 15% fetal bovine serum (FBS), 2 mM Glutamine, 1× Non-essential amino acids and 0.055 mM 2-mercaptoethanol. High quality of ESCs (< 50 passages) routinely tested negative for mycoplasma are highly recommended for all experiments. Tetramethylrhodamine Methyl Ester (TMRM) preparation: dissolve 25 mg of TMRM into 5 mL of DMSO to get 10 mM solution. To prepare a stock concentration of 100 μM, add 10 μL of 10 mM TMRM solution into 990 μL of DMSO. All TMRM solutions should be stored at −20°C and used within 6 months. To avoid detrimental effects of freeze-thaw cycles, TMRM solutions are strongly recommended to aliquot for a single use. Staining buffer preparation: add 10 mM HEPES and 2% FBS into Phenol red-free Hanks’ Balanced Salt Solution (HBSS) 1×. FBS needs to be heat-inactivated at 56°C for 30 min, mix well and stored at 4°C. FACS running buffer: add 10 mM HEPES into N2B27 medium. FACS collection buffer: add 10 mM HEPES and 2% FBS into N2B27 medium.

Key Resources Table

Step-By-Step Method Details

ESCs are heterogenous with regard to mitochondrial activity (Khoa et al., 2020; Schieke et al., 2008). However, a detailed protocol for determining the biological features of distinct mitochondrial activity is currently lacking. In this section, we list step-by-step procedures, timing as well as critical considerations that ensure success. Following this protocol would result in a successful isolation of quiescent ESCs with intact pluripotent features.

ESC Culture

Timing: 2 days Mouse E14 ESC line is maintained on Geltrex-coated 6-well plates at 37°C and 5% CO2 in 2 mL of N2B27/2i/LIF culture media per well. To keep the cells growing at relatively stable density, we usually seed 1–2 x 105 cells per well onto 6-well plates after each split. Medium change is performed daily. Cells are passaged every two days as follows: Pre-warm N2B27, N2B27/2i/LIF, Accutase and DPBS for 5 min at 37°C. All reagents are in 15 mL or 50 mL conical tubes. Gently aspirate the old medium and wash the cells once with DPBS. Incubate the cells with 400 μL of Accutase at 37°C for 4 min. Add 1.5 mL of N2B27 medium, gently pipette up and down for ten times and collect cells by centrifugation at 300 × g, RT for 3 min. Resuspend the cells in 1 mL of N2B27/2i/LIF media. Count the cell numbers by hemocytometer and place cells at a density of 1–2 x 105 cells per well of 6-well plate. 2 mL of N2B27/2i/LIF culture media per well are used throughout the culture. Return the cell plate to the incubator and gently shake the plate to distribute the cells evenly. CRITICAL: Cell density plays critical roles in maintaining ESC identity as well as the metabolic status. In our experiences, plating ESCs at a density of 1–2 x 105 cells per well of 6-well plate often results in 70%–80% confluency after 2 days in culture (Figure 1A). This can give rise to a consistent cell cycle profile (Figure 1B) as well as fraction of cells with low mitochondrial membrane potential, which are determinant factors in our protocol. Researchers can use our seeding density as a starting point to scale up or down according to their plate formats.
Figure 1

Routine Culture of Ground-State ESCs

(A) Representative bright-field image of E14 ESCs at day 2 after passage. 70%–80% confluency is optimal for derivation of quiescent ESCs. Scale bar, 100 μm.

(B) Representative plot of cell cycle analysis determined by double staining live cells with Hoechst 33342 and Pyronin Y. Percentages of each phase of cell cycles are shown. For detailed protocol of cell cycle analysis, see Khoa et al. (2020).

Routine Culture of Ground-State ESCs (A) Representative bright-field image of E14 ESCs at day 2 after passage. 70%–80% confluency is optimal for derivation of quiescent ESCs. Scale bar, 100 μm. (B) Representative plot of cell cycle analysis determined by double staining live cells with Hoechst 33342 and Pyronin Y. Percentages of each phase of cell cycles are shown. For detailed protocol of cell cycle analysis, see Khoa et al. (2020).

TMRM Staining of ESCs

Timing: 1 h TMRM is a cell-permeable dye that can label functioning mitochondria. As such, cells with active mitochondrial membrane potential (ΔΨ) tend to accumulate more TMRM than those harboring lower ΔΨ. Here, we present a step-by-step procedure of TMRM staining at single-cell levels. Preparation of single-cell suspension and reagents for staining. Inspect the cells under a microscope to confirm the cell density, and make sure the culture is not contaminated at the time of staining. Gently aspirate the old medium and wash the cells once with DPBS. Dissociate cells with 400 μL of Accutase at 37°C for 4 min. Tap the plate to facilitate the detachment of colonies. Cells are gently pipetted up and down ten times, resuspended in 37°C pre-warmed FACS running buffer and centrifuged at 300 × g, RT for 3 min. Resuspend the cells in 1 mL of 37°C pre-warmed staining buffer. Take out an aliquot of 100 μM TMRM, and leave at RT. TMRM staining Count the cells by hemocytometer and adjust the cell numbers at a density of 1 x 106 cells/mL. Add TMRM at a final concentration of 25 nM. Gently pipette up and down for ten times to mix the cells. Incubate cells at 37°C and 5% CO2 for 15 min. Wash the cells twice in ice-cold FACS running buffer by centrifugation at 300 × g, 4°C for 3 min. Resuspend the cells in ice-cold FACS running buffer containing SYTOXTM Blue (1:1,000 dilution). Cells are filtered through 40 μm sterile cell strainer, left on ice, and protected from light by aluminum foil until FACS. CRITICAL: TMRM should be protected from lights. Each aliquot of TMRM is for a single use. to set up the gating strategy, two additional samples are needed: unstained cells and SYTOXTM Blue-stained cells. Since there is always a small subpopulation of dead cells in culture that can be used for setting up the gating (Figure 2), inducing cell death for a positive control is not necessary.
Figure 2

A Representative Gating Strategy for FACS Sorting

To set the boundaries, the unstained and SYTOXTM Blue-stained samples are used for gating. First, cell population is identified by SSC-A versus FSC-A plots (Gate 1). Doublets are then eliminated using FSC-A versus FSC-W and SSC-A versus SSC-W plots (Gate 2 and 3). Dead cells are removed by SYTOXTM Blue (Gate 4). Then, cell populations negative for SYTOXTM Blue are gated for TMRM (Gate 5). Finally, three cell populations are defined for sorting (Gate 6). They include cells of <5% low TMRM fluorescence intensity (1), <5% high TMRM fluorescence intensity (2) and the whole cell population (3).

A Representative Gating Strategy for FACS Sorting To set the boundaries, the unstained and SYTOXTM Blue-stained samples are used for gating. First, cell population is identified by SSC-A versus FSC-A plots (Gate 1). Doublets are then eliminated using FSC-A versus FSC-W and SSC-A versus SSC-W plots (Gate 2 and 3). Dead cells are removed by SYTOXTM Blue (Gate 4). Then, cell populations negative for SYTOXTM Blue are gated for TMRM (Gate 5). Finally, three cell populations are defined for sorting (Gate 6). They include cells of <5% low TMRM fluorescence intensity (1), <5% high TMRM fluorescence intensity (2) and the whole cell population (3).

FACS-Based Isolation of Quiescent ESCs

Timing: 30 min to 1 h We recently reported that ground-sate ESCs with low ΔΨ (i.e., low TMRM) exhibit defined features of the quiescent state, such as reduced RNA content and extremely slow proliferation rate (Khoa et al., 2020). Here we provide a detailed gating strategy for capturing quiescent ESCs after TMRM staining. Cell sorting based on the intensity of TMRM signals is performed using the MoFlo Astrios Cell Sorter (BECKMAN COULTER life Sciences). TMRM can be detected by the RFP filter set with absorbance peak at 548 nm and emission peak at 574 nm. Excitation and emission of SYTOXTM Blue are at 444 nm and 480 nm, respectively, which are detectable with the 405 nm violet laser light. Gating strategy is shown in Figure 2. Collect cells in 15 mL tubes containing FACS collection buffer. After sorting, gently invert the collection tubes in order to resuspend cells attached on the tube’s wall. Centrifuge the sorted cells at 300 × g for 5 min. Carefully remove the supernatant and resuspend the cells in 1 mL of N2B27/2i/LIF or EB differentiation media. CRITICAL: To lessen potential cell death due to the time-consuming process of FACS sorting, the cell concentration needs to be optimized appropriately. We recommend quickly performing FACS within 1 h after TMRM staining and use SYTOXTM Blue dye for staining to exclude the dead cells. TMRM and SYTOXTM Blue are light sensitive. All samples and FACS collection tubes should be protected from light and kept on ice during sorting operation.

Validating Pluripotent Features of Quiescent ESCs: Measure Total RNA Amounts per Cell

Timing: variable Diapaused embryos can resume their normal development in response to favorable environments (He et al., 2019; Renfree and Fenelon, 2017). To determine whether quiescent ESCs are capable of responding to distinct environmental cues, we analyze their behaviors under self-renewal and differentiation conditions. A canonical characteristic of quiescent stem cells is the drastic reduction in RNA content as a result of minimal metabolic activity, low DNA replication, and slow cell cycle progression. Total amounts of RNAs in each cell are determined as previously described (Khoa et al., 2020). Equal cell numbers of top and bottom <5% of TMRM fluorescence intensity are sorted as above (Figure 2). We use the RNeasy mini kit (QIAGEN) to extract total RNAs. Extracted RNAs are stored at −80°C, and thawed on ice prior to further analyses. Quantifications of RNA amounts are performed using QubitTM RNA HS assay kit. Data are normalized against the cell numbers (Figure 3).
Figure 3

Total RNA Amounts Per Cell

Live cells of high and low ΔΨ are sorted and total RNAs are immediately isolated (see step 10). Data are shown as means ± SEM from five independent experiments. Data from Khoa et al., 2020. Statistical analyses are determined by GraphPad Prism 7.0 software. p values are calculated by the two-tailed Student’s t test. ∗∗∗p < 0.001. SEM, standard error of the mean.

Total RNA Amounts Per Cell Live cells of high and low ΔΨ are sorted and total RNAs are immediately isolated (see step 10). Data are shown as means ± SEM from five independent experiments. Data from Khoa et al., 2020. Statistical analyses are determined by GraphPad Prism 7.0 software. p values are calculated by the two-tailed Student’s t test. ∗∗∗p < 0.001. SEM, standard error of the mean.

Validating Pluripotent Features of Quiescent ESCs: Colony Formation

Timing: 5 days To examine the self-renewal capacity of low ΔΨ cells (i.e., quiescent ESCs) as compared to high ΔΨ cells, we seed sorted cells with distinct TMRM signals at clonal density for colony formation assay. Seed 500 sorted cells per well of Geltrex-coated 6-well plates in 2 mL of N2B27/2i/LIF culture media. Cells are cultured for 5 days in N2B27/2i/LIF media. Medium change starts 2 days after initial seeding and is subsequently performed every other day. At day 5, the old media are discarded. Cells are washed once with DPBS containing Calcium Chloride and Magnesium Chloride (i.e., DPBS (+)) and fixed with 1 mL of 4% paraformaldehyde (PFA)/DPBS (+) at RT for 10 min. Fixed cells are then washed once with UltraPureTM DNase/RNase-Free distilled H2O and subjected for alkaline phosphatase (AP) staining in accordance with manufacturer’s instructions (Figure 4).
Figure 4

Colony Formation Assay

Left, AP staining in sorted high and low TMRM cells. Scale bar, 100 μm. Right, qualifications of AP-positive colonies from left. Data are shown as means ± SEM from three biological replicates. ∗∗∗p < 0.001.

Images were captured by the color scanner (Epson) and the IX73 microscope system (Olympus). CRITICAL: Medium change should be carefully implemented during the course of the experiment. Tilt the dish at a 45°C angle, wait 5 s, gently remove the old media and replenish with the fresh media. Because the colony is easy to detach from the dish, we recommend using the pipette tips to change the media. At the step 13, we recommend washing the cells with DPBS (+) to help avoid the detachment of the colonies. Colony Formation Assay Left, AP staining in sorted high and low TMRM cells. Scale bar, 100 μm. Right, qualifications of AP-positive colonies from left. Data are shown as means ± SEM from three biological replicates. ∗∗∗p < 0.001.

Validating Pluripotent Features of Quiescent ESCs: Immunofluorescence for OCT3/4

Timing: 2 days OCT3/4 is a canonical factor that plays an indispensable role in maintenance of ESC pluripotency. To investigate the expression levels of OCT3/4 in high and low ΔΨ cells, we perform immunofluorescence as follows: Seed sorted high and low TMRM cells onto Geltrex-coated Lab-Tek II Chamber cover glass. Cells are grown for 24 h prior to OCT3/4 immunofluorescence analysis using the standard protocol. Fix cells in 4% PFA/DPBS (+) for 30 min at 4°C. Wash cells twice with DPBS (+). Permeabilize cells in 0.25% Triton X-100/DPBS (+) (PBST) for 30 min at 4°C. Block cells in blocking solution containing 10% Goat serum in DPBS (+) for 1 h at 4°C. Incubate cells with anti-OCT3/4 antibody (1:50) diluted in blocking solution for 14 h at 4°C. Wash cells with 0.25% PBST three times with gentle shaking for 5 min each, and incubate cells with Goat anti-Mouse IgG FITC-conjugated secondary antibody for 1 h at RT. Wash cells with 0.25% PBST three times with gentle shaking for 5 min each and stain cells with DAPI diluted in 0.25% PBST for 10 min at RT. Wash cells with DPBS (+) three times. Cells are ready for imaging (Figure 5).
Figure 5

OCT3/4 Immunofluorescence

Left, representative images of immunofluorescence of OCT3/4. Nuclei are co-stained with DAPI. Scale bar, 50 μm. Right, qualifications of fluorescence intensity in each cell from left by ImageJ. Data are shown as mean ± SEM. n.s. not significant. n, number of cells. MFI, mean fluorescence intensity.

Images are captured using the Leica SP5 upright 2-photon confocal microscope (Leica Microsystems). Relative fluorescence intensities are quantified in each cell using ImageJ (Figure 5). OCT3/4 Immunofluorescence Left, representative images of immunofluorescence of OCT3/4. Nuclei are co-stained with DAPI. Scale bar, 50 μm. Right, qualifications of fluorescence intensity in each cell from left by ImageJ. Data are shown as mean ± SEM. n.s. not significant. n, number of cells. MFI, mean fluorescence intensity.

Validating Pluripotent Features of Quiescent ESCs: TMRM and PECAM-1 Co-staining

Timing: 2.5 h The purpose of this experiment is to provide evidence that low TMRM cells (i.e., quiescent ESCs) in bulk culture are still pluripotent using cell-surface marker PECAM-1 staining. To additionally characterize the pluripotent features of quiescent ESCs in bulk culture, cells are stained for platelet endothelial cell adhesion molecule 1 (PECAM-1, also known as CD31). PECAM-1 protein is highly expressed in the inner cell mass of blastocysts and in ESCs (Robson et al., 2001; Rugg-Gunn et al., 2012). We develop a co-staining protocol for TMRM and PECAM-1 to determine the expression levels of PECAM-1 in distinct fractions of high and low TMRM cells. Repeat from step 3 to step 4d. Resuspend the cells in 5 mL of the cell staining buffer, centrifuge at 300 × g, 4°C for 5 min and discard the supernatant. In 1.5 mL Eppendorf tube, add 1 μg of TruStain FcXTM in 100 μL staining buffer (1:50) for blocking reaction, gently mix and incubate for 10 min on ice. Add 1 μg of PECAM-1 antibody (1:50) and incubate for 20 min on ice. Wash cells twice with 1 mL of the cell staining buffer and spin at 300 × g, 4°C for 5 min. Add 0.25 μg of APC/Fire™ 750 Goat anti-rat IgG diluted in 100 μL of the staining buffer (1:80) and incubate 20 min on ice in dark. Wash cells twice with 1 mL of the cell staining buffer and spin at 300 × g, 4°C for 5 min. Resuspend cells with 0.5 mL of the cell staining buffer containing SYTOXTM Blue (1:1,000) to exclude dead cells. Samples are ready for flow cytometry (Figure 6).
Figure 6

Double Staining of TMRM and PECAM-1 in ESCs

(A) Summary of gating strategy. Unstained, TMRM, SYTOXTM Blue, PECAM-1 or IgG-stained samples are used for setting the boundaries (see also Figure 2). Cells of <5% low TMRM and <5% high TMRM signals are subjected for PECAM-1 analysis.

(B and C) Quantifications of TMRM intensity (B) and PECAM-1 expression (C) from (A). Data are presented as mean ± SEM from four biological replicates. ∗∗∗p < 0.001; n.s. not significant. MFI, mean fluorescence intensity.

CRITICAL: We do not recommend staining PECAM-1 after TMRM sorting, because the time-consuming FACS sorting per se coupled with PECAM-1 staining afterward would cause profound cell death as well as drastic changes in the metabolic state of the cells. Instead, using the protocol and gating strategy described above would allow for integrative analyses of the pluripotent marker and ΔΨm in bulk ESCs. In addition to single stained samples, including IgG sample is important for compensation and elimination of unspecific signals. Double Staining of TMRM and PECAM-1 in ESCs (A) Summary of gating strategy. Unstained, TMRM, SYTOXTM Blue, PECAM-1 or IgG-stained samples are used for setting the boundaries (see also Figure 2). Cells of <5% low TMRM and <5% high TMRM signals are subjected for PECAM-1 analysis. (B and C) Quantifications of TMRM intensity (B) and PECAM-1 expression (C) from (A). Data are presented as mean ± SEM from four biological replicates. ∗∗∗p < 0.001; n.s. not significant. MFI, mean fluorescence intensity.

Validating Pluripotent Features of Quiescent ESCs: Embryoid Body (EB) Differentiation

Timing: 13 days To explore whether quiescent ESCs (i.e., low TMRM cells) undergo normal differentiation in vitro, we perform EB formation using all three TMRM-sorted populations (see step 5 and Figure 2). 2000 FACS-sorted cells of high, low and whole TMRM signals are seeded onto each well of the NunclonTM SpheraTM 96U plate format consisting of 200 μL EB media. EBs are cultured in suspension at 37°C and 5% CO2. Half of medium is replaced every other day. EB formation is recorded at day 3 and 5 (Figure 7A), whereas beating EBs are counted at day 9 (Figure 7B).
Figure 7

EB Differentiation

(A) EB morphology at indicated conditions. Scale bar, 200 μm. EB, embryoid body.

(B) Efficiency of beating EBs. Percentages are calculated by the number of beating EBs from total EBs.

(C) Representative bright-field image of outgrowth EBs at day 8. Scale bar, 200 μm.

At day 5, EBs are transferred to gelatin-coated plates for additional 8-day differentiation (Figure 7C). CRITICAL: For EB formation of FACS-sorted cells, we recommend using the NunclonTM SpheraTM 96U plate format to reproducibly generate single EBs with uniform sizes. EB Differentiation (A) EB morphology at indicated conditions. Scale bar, 200 μm. EB, embryoid body. (B) Efficiency of beating EBs. Percentages are calculated by the number of beating EBs from total EBs. (C) Representative bright-field image of outgrowth EBs at day 8. Scale bar, 200 μm.

Expected Outcomes

We show here a straightforward protocol for in vitro derivation of quiescent ESCs. In our protocol, ESCs are cultured under the ground-state condition (i.e., 2i/LIF) with consistent density and cell cycle profiles (Figure 1). By following our cell culture conditions, one can not only obtain typical cell cycle profile of ground-state ESCs (Ter Huurne et al., 2017), but also robustly identify a fraction of cells that reside in G0 phase (<5%) (Figure 1). Using our gating strategy, cells with distinct levels of ΔΨm can be FACS-isolated and subsequently analyzed (Figure 2). We demonstrate that the low ΔΨm cells exhibit features of quiescent state. They display low RNA contents and reduced self-renewal in colony formation assay, yet maintain high expression levels of pluripotency markers such as AP, OTC3/4 and PECAM-1 (Figures 3, 4, 5, and 6). Importantly, these quiescent ESCs can undergo normal differentiation through three-dimensional EB formation in a suspension culture, similar to that of bulk ESCs (Figure 7). It is important to note that at day 3 of EB differentiation, the low ΔΨm cells form EBs with smaller sizes than the whole and high ΔΨm cells (Figure 7A). However, EB sizes become comparable in all levels of ΔΨm cells at day 5 (Figure 7A).

Limitations

Cell culture condition is crucial for obtaining the reproducible data, yet affected by multiple factors such as splitting ratio, status of starting cell lines and reagents. A strict adherence to our cell culture protocol is highly recommended. It is important to note that we have not tested our protocol in ESCs cultured in serum/LIF medium, which have higher degree of heterogeneity than the ground-state ESCs (Chambers et al., 2007; Marks et al., 2012). We anticipate that our protocol can be applied to other pluripotent stem cell types (e.g., epiblast stem cells and human ESCs), which show distinct levels of metabolic and transcriptional heterogeneity (Khoa le et al., 2016; Messmer et al., 2019; Zhang et al., 2016; Zhou et al., 2012). Our protocol enables isolation of a small population of cells (<5%) that has low ΔΨm. These cells display biological characteristics of quiescence. However, we have not yet determined whether the low ΔΨm cells are equivalent to those in G0 phase (Figure 1B). To clarify this intriguing point, scientists may consider using knockin reporter cell lines that facilitate the simultaneous evaluation of those two parameters. Finally, although our protocol reveals biological features of low ΔΨm quiescent ESCs that may represent embryonic diapause in vivo, in-depth comparisons of transcriptome and epigenome between low ΔΨm quiescent ESCs and diapaused epiblasts are needed. In addition, advantages of low ΔΨm quiescent ESCs with respect to directed differentiation as compared to self-renewing ESCs warrant further investigations.

Troubleshooting

Problem 1

In ESC culture step: cells exhibit signs of differentiation and flattened colony morphology (steps 1 and 2).

Potential Solution

Researchers should double check the expiration date of basal N2B27 medium and Geltrex. N2B27 medium should be used within one week. Suboptimal N2B27 may introduce unexpected biases in cell culture, including flattened colony morphology. It is worth paying attention to each component of N2B27 medium when a new lot is used. For preparation of ready-to-use Geltrex, researchers are highly recommended to follow our protocol (see “Geltrex preparation” step). Finally, overgrowth may lead to indiscernible signs of differentiation, which results from seeding inappropriate cell numbers. High cell density can lead to unhealthy colonies and spontaneous differentiation. Whenever those problems arise, the cell culture should be discarded and replaced with new cell stock.

Problem 2

There are no significant differences between the high and low ΔΨ cells with regard to self-renewal capacity, total RNA amounts per cell and EB differentiation (steps 3–9). Researchers should pay attention to changes in the gating during the course of FACS sorting to ensure that cells of <5% of low TMRM intensity are sorted. This can be accomplished by keyboard-mediated manual adjustment. In our experiences, sorting cells of <5% of the low TMRM signals always leads to reproducible derivation of quiescent ESCs. We strongly recommend testing stabilization of the gating for at least 30 s before performing the actual FACS sorting. In addition, TMRM, when used at high concentrations, can result in unspecific signals by labeling other cellular compartments. Therefore, TMRM concentrations need to be optimized.

Resource Availability

Lead Contact

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Yali Dou (yalidou@usc.edu).

Materials Availability

This study did not generate new unique reagents.

Data and Code Availability

This study did not generate any unique datasets or code.
N2B27/2i/LIF Media (Make 40 mL)Final ConcentrationAmount
DMEM/F12N/A19.274 mL
NeurobasalN/A19.274 mL
N2 (100×)400 μL
B27 (50×)0.5×400 μL
Glutamine (200 mM)2 mM200 μLa
Penicillin/streptomycin (10,000 U/mL)100 U/mL400 μL
2-mercaptoethanol (55 mM)0.055 mM40 μL
2i (PD0325901, 5 mM plus CHIR99021, 15 mM)PD0325901, 1 μM plus CHIR99021, 3 μM8 μL
LIF (107 units/mL)1,000 units/mL4 μL

Since DMEM/F12 already contains L-Glutamine, only another 200 μL is required.

EB Media (Make 40 mL)Final ConcentrationAmount
KnockOut™ DMEMN/A33.160 mL
Fetal bovine serum (FBS)15%6 mL
Glutamine (200 mM)2 mM400 μL
Non-essential amino acids (100×)400 μL
2-mercaptoethanol (55 mM)0.055 mM40 μL
Staining Buffer (Make 40 mL)Final ConcentrationAmount
HEPES 1M10 mM400 μL
FBS2%800 μL
Phenol red-free Hanks’ Balanced Salt Solution (HBSS) 1×N/A38.8 mL
FACS running buffer (Make 40 mL)Final ConcentrationAmount
HEPES 1M10 mM400 μL
N2B27 mediumN/A39.6 mL
FACS Running Buffer (Make 40 mL)Final ConcentrationAmount
HEPES 1M10 mM400 μL
FBS2%800 μL
N2B27 mediumN/A38.8 mL
REAGENT or RESOURCESOURCEIDENTIFIER
Antibodies

Anti-OCT3/4Santa Cruz BiotechnologyCat#sc-5279; RRID:AB_628051
Anti-PECAM-1BiolegendCat#102402; RRID: AB_312897
APC/FireTM 750 Goat anti-Rat IgGBiolegendCat#405426; RRID:AB_2687098
Rat IgG Isotype ControlThermo Fisher ScientificCat#31933; RRID: AB_10959892
Goat anti-Mouse IgG FITC-conjugatedThermo Fisher ScientificCat#62-6511; RRID:AB_2533946
TruStain FcXTM (anti-mouse CD16/32)BiolegendCat#101320; RRID:AB_1574975

Chemicals, Peptides, and Recombinant Proteins

ESGRO® leukemia inhibitory factor (LIF)EMD MilliporeCat#ESG1107
PD0325901SIGMA ALDRICHCat#PZ0162
CHIR99021SIGMA ALDRICHCat#SML1046
Dimethyl Sulfoxide (DMSO)SIGMA ALDRICHCat#D8418
GeltrexThermo Fisher ScientificCat#A1413202
0.1% Gelatin SolutionMilliporeCat#ES-006-B
N2 supplement (100×)Thermo Fisher ScientificCat#17502001
B27 supplement (50×)Thermo Fisher ScientificCat#17504-044
KnockOut™ DMEM mediumThermo Fisher ScientificCat#10829018
2-mercaptoethanolThermo Fisher ScientificCat#21985023
Penicillin/StreptomycinThermo Fisher ScientificCat#15140122
GlutamineThermo Fisher ScientificCat#25030-024
DMEM/F12Thermo Fisher ScientificCat#11320-033
NeurobasalThermo Fisher ScientificCat#21103-049
Fetal Bovine Serum (FBS)Atlas BiologicalsCat#F-0500-D
HEPES 1MThermo Fisher ScientificCat#15630106
Hanks’ Balanced Salt Solution (HBSS) 1×GibcoTMCat#14175-095
Dulbecco’s Phosphate-Buffered Saline (DPBS)GibcoTMCat#14190-144
DPBS containing Calcium Chloride and Magnesium Chloride (DPBS(+))GibcoTMCat#14040-133
UltraPureTM DNase/RNase-Free distilled H2OThermo Fisher ScientificCat#10977-015
AccutaseGibcoTMCat#A1110501
Cell staining bufferBiolegendCat#420201
ParaformaldehydeTed Pella Inc.Cat#18505
Triton X-100SIGMA ALDRICHCat#93443
Goat serumCell Signaling TechnologyCat#5425
SYTOXTM BlueThermo Fisher ScientificCat#S34857
Tetramethylrhodamine methyl ester (TMRM)Thermo Fisher ScientificCat#T668
Hoechst 33342Thermo Fisher ScientificCat#62249
Pyronin YSIGMA ALDRICHCat#213519

Critical Commercial Assays

VECTOR® Red Alkaline Phosphatase KitVector LaboratoriesCat#SK-5100
LookOut® Mycoplasma PCR Detection KitSIGMA ALDRICHCat#MP0035
QubitTM RNA HS assay kitThermo Fisher ScientificCat#Q32855

Experimental Models: Cell Lines

Mouse ESCs: E14tg2aATCCCat#CRL-1821TM

Software and Algorithms

ImageJSchneider et al., 2012https://imagej.nih.gov/ij/
GraphPad Prism, v7GraphPadhttps://www.graphpad.com/scientific-software/prism/
FlowJo, v10.0.7r2FlowJo LLChttp://docs.flowjo.com

Other

NunclonTM SpheraTM 96U plate dishesThermo Fisher ScientificCat#174932
Multiwell Tissue Culture Plate, 6 wellCorningCat#353046
Multiwell Tissue Culture Plate, 24 wellCorningCat#353047
MoFlo Astrios Cell SorterBECKMAN COULTER life SciencesN/A
Leica SP5 upright 2-photon confocal microscopeLeica MicrosystemsN/A
Lab-Tek II Chamber CoverglassThermo Fisher ScientificCat#155382
  14 in total

1.  Nanog safeguards pluripotency and mediates germline development.

Authors:  Ian Chambers; Jose Silva; Douglas Colby; Jennifer Nichols; Bianca Nijmeijer; Morag Robertson; Jan Vrana; Ken Jones; Lars Grotewold; Austin Smith
Journal:  Nature       Date:  2007-12-20       Impact factor: 49.962

2.  Distinct Metabolic States Can Support Self-Renewal and Lipogenesis in Human Pluripotent Stem Cells under Different Culture Conditions.

Authors:  Hui Zhang; Mehmet G Badur; Ajit S Divakaruni; Seth J Parker; Christian Jäger; Karsten Hiller; Anne N Murphy; Christian M Metallo
Journal:  Cell Rep       Date:  2016-07-28       Impact factor: 9.423

3.  Blastocyst activation engenders transcriptome reprogram affecting X-chromosome reactivation and inflammatory trigger of implantation.

Authors:  Bo He; Hangxiao Zhang; Jianqi Wang; Mengying Liu; Yang Sun; Chuanhui Guo; Jinhua Lu; Haibin Wang; Shuangbo Kong
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-25       Impact factor: 11.205

4.  Inner cell mass-specific expression of a cell adhesion molecule (PECAM-1/CD31) in the mouse blastocyst.

Authors:  P Robson; P Stein; B Zhou; R M Schultz; H S Baldwin
Journal:  Dev Biol       Date:  2001-06-15       Impact factor: 3.582

Review 5.  The enigma of embryonic diapause.

Authors:  Marilyn B Renfree; Jane C Fenelon
Journal:  Development       Date:  2017-09-15       Impact factor: 6.868

6.  NIH Image to ImageJ: 25 years of image analysis.

Authors:  Caroline A Schneider; Wayne S Rasband; Kevin W Eliceiri
Journal:  Nat Methods       Date:  2012-07       Impact factor: 28.547

7.  Mitochondrial metabolism modulates differentiation and teratoma formation capacity in mouse embryonic stem cells.

Authors:  Stefan M Schieke; Mingchao Ma; Liu Cao; J Philip McCoy; Chengyu Liu; Nancy F Hensel; A John Barrett; Manfred Boehm; Toren Finkel
Journal:  J Biol Chem       Date:  2008-08-18       Impact factor: 5.157

8.  Cell-surface proteomics identifies lineage-specific markers of embryo-derived stem cells.

Authors:  Peter J Rugg-Gunn; Brian J Cox; Fredrik Lanner; Parveen Sharma; Vladimir Ignatchenko; Angela C H McDonald; Jodi Garner; Anthony O Gramolini; Janet Rossant; Thomas Kislinger
Journal:  Dev Cell       Date:  2012-03-15       Impact factor: 12.270

9.  The transcriptional and epigenomic foundations of ground state pluripotency.

Authors:  Hendrik Marks; Tüzer Kalkan; Roberta Menafra; Sergey Denissov; Kenneth Jones; Helmut Hofemeister; Jennifer Nichols; Andrea Kranz; A Francis Stewart; Austin Smith; Hendrik G Stunnenberg
Journal:  Cell       Date:  2012-04-27       Impact factor: 41.582

10.  Visualization of the Epiblast and Visceral Endodermal Cells Using Fgf5-P2A-Venus BAC Transgenic Mice and Epiblast Stem Cells.

Authors:  Le Tran Phuc Khoa; Takuya Azami; Tomoyuki Tsukiyama; Jun Matsushita; Setsuko Tsukiyama-Fujii; Satoru Takahashi; Masatsugu Ema
Journal:  PLoS One       Date:  2016-07-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.